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Acquisition of specific neuronal identity by individual brain nuclei is a key step in brain
development. However, how the mechanisms that confer neuronal identity are integrated
with upstream regional specification networks is still mysterious. Expression of Sonic
hedgehog (Shh), is required for hypothalamic specification and is later downregulated
by Tbx3 to allow for the differentiation of the tubero-mamillary region. In this region, the
mamillary body (MBO), is a large neuronal aggregate essential for memory formation. To
clarify how MBO identity is acquired after regional specification, we investigated Lhx5,
a transcription factor with restricted MBO expression. We first generated a hypomorph
allele of Lhx5—in homozygotes, theMBOdisappears after initial specification. Intriguingly,
in these mutants, Tbx3 was downregulated and the Shh expression domain abnormally
extended. Microarray analysis and chromatin immunoprecipitation indicated that Lhx5
appears to be involved in Shh downregulation through Tbx3 and activates several
MBO-specific regulator and effector genes. Finally, by tracing the caudal hypothalamic
cell lineage we show that, in the Lhx5 mutant, at least some MBO cells are present but
lack characteristic marker expression. Our work shows how the Lhx5 locus contributes
to integrate regional specification pathways with downstream acquisition of neuronal
identity in the MBO.
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Introduction
The hypothalamus is a brain region with essential roles in homeostasis and behavior (see
for instance, Saper and Lowell, 2014). Alterations of its complex development can lead to
pathological conditions in adults (Caqueret et al., 2005). The hypothalamus is subdivided into
highly differentiated regions formed by functionally and morphologically highly differentiated
neuronal aggregates, the hypothalamic nuclei. The induction and specification of the hypothalamus
in general has been the subject of numerous studies in a variety of animal models (reviewed
in Machluf et al., 2011; Pearson and Placzek, 2013). These have identified important roles for
Shh, BMP, Wnt, FGF, and Nodal signaling. Although these well-known signaling pathways have
been shown to specify the hypothalamus as a region, as well as determining its dorso-ventral,
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antero-posterior, and latero-medial axes, how the specification of
individual nuclei is regulated remains elusive.
One particularly important region is the mamillary region,
including its main nucleus, the mamillary body (MBO). The
MBO is a large and compact neuronal aggregate acting as a
hub between hindbrain, thalamus, and hippocampus through
major afferent and efferent axonal bundles. The MBO has
key functions in foraging behavior as in memory formation
(Vann and Aggleton, 2004; Vann, 2013). Loss of the MBO
in Foxb1 mutant mice leads to deficits in working memory
(Radyushkin et al., 2005). In humans, MBO degeneration
is involved in the anterograde amnesia characteristic of the
Wernicke-Korsakoff syndrome (Kahn and Crosby, 1972), a
serious neurological condition connected to alcohol abuse
(Kopelman et al., 2009) and bariatric surgery (Koffman et al.,
2006). Although analysis of mouse and zebrafish mutants has
shown that transcription factors Sim1 and 2, Foxb1, and Fezf2
are required for MBO development and survival (Alvarez-
Bolado et al., 2000a; Marion et al., 2005; Wolf and Ryu,
2013), little is known about the genetic regulation of MBO
development.
Forebrain expression of Sonic hedgehog (Shh), which encodes
a secreted protein with morphogen properties, is essential for
appropriate hypothalamic regional specification (Szabó et al.,
2009). The hypothalamic Shh expression domain, however, has
to be downregulated in the mamillary region in order for it
to differentiate (Manning et al., 2006). The T-box (Tbx) family
of transcription factor genes has essential roles in development
(Naiche et al., 2005; Greulich et al., 2011; Wansleben et al.,
2014). Work on zebrafish has shown that Wnt inhibition is
necessary for hypothalamic differentiation (Kapsimali et al.,
2004), and in chick BMP signaling leads to Wnt inhibition and
subsequent upregulation of T-box gene Tbx2, which specifically
represses Shh in the tuberal and mamillary regions allowing
them to differentiate (Manning et al., 2006). This role of
Tbx2 is performed by Tbx3 in the mouse (Trowe et al.,
2013). What is not clear is how the downregulation of Shh
translates into nuclear formation and how nucleogenesis is
integrated in the regulatory networks of regional specification
mechanisms.
LHX5 is a member of the LHX family of transcription
factors acting as important differentiation determinants (Hobert
and Westphal, 2000; Kadrmas and Beckerle, 2004), and
it is strongly expressed in the caudal hypothalamus from
very early stages (E9.5) through the time of formation of
recognizable neuronal aggregates (Figures 1A–D) (Sheng et al.,
1997; Allen-Institute-for-Brain-Science, 2009; Shimogori et al.,
2010). Lhx5 has specific roles in forebrain development—
e.g., it is essential for hippocampal development (Zhao et al.,
1999) and regulates the distribution of Cajal-Retzius neurons
(Miquelajáuregui et al., 2010). Here we created a novel mutant
allele of Lhx5 and analyzed it using expression profiling with
microarrays, ChIP-Seq and luciferase experiments, as well as
examination of the hypothalamus of the Tbx3−/−. Our results
indicate that Lhx5 has an essential role in several different
developmental pathways regulating MBO specification and
differentiation.
FIGURE 1 | Expression of Lhx5 in the mamillary region. In situ
hybridization for Lhx5 on sagittal sections (rostral to the left) of E11.5 (A,B) and
E18.5 (C,D) brains. Lhx5 is expressed in the ventricular zone (neuroepithelium;
arrow in (A) and inset in (A) as well as in the incipient mamillary mantle layer
(arrow in B). At E18.5, the MBO is prominently and specifically labeled in the
mamillary region (framed in C, magnified in D). Abbreviations: 4V, fourth
ventricle; ac, anterior commissure; cf, cephalic flexure; MB, midbrain; MBO,
mamillary body; MO, medulla oblongata; P, pons; Th, thalamus. In (C,D) a
dashed line brings out the contour of the brain. Scale bars: 500µm.
Materials and Methods
Mouse Lines
Animals were housed and handled in ways that minimize
pain and discomfort, in accordance with German animal
welfare regulations (Tierschutzgesetz) and in agreement
with the European Communities Council Directive
(2010/63/EU). The authorization for the experiments
was granted by the Regierungspräsidium Karlsruhe (state
authorities) and the experiments were performed under
surveillance of the Animal Welfare Officer of the University
of Heidelberg responsible for the Institute of Anatomy and
Cell Biology. To obtain embryos, timed pregnant females
of the appropriate crossings were sacrificed by cervical
dislocation.
Conditional Lhx5 Mutant (Lhx5fl/+)
We generated a novel conditional allele of Lhx5 by homologous
recombination. We cloned the conditional Lhx5 targeting
construct by inserting loxP sites into the Lhx5 locus spanning
a region from intron 1 to intron 4 including exons 2–4
(Figures 2A–C).
Foxb1Cre−eGFP/+ Mutant Mice
In this line (Zhao et al., 2007), the Foxb1 coding sequence
has been replaced by a Cre-IRES-eGFP cassette by homologous
recombination, and this allele expresses Cre and eGFP under
the control of the regulatory sequences of Foxb1. These
mice show Cre expression in the thalamic and hypothalamic
neuroepithelium (Zhao et al., 2007, 2008). We used only
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FIGURE 2 | Generation of a novel Lhx5mutant allele. (A–C) Lhx5 wild
type allele, floxed allele and recombined allele, as indicated. Exons 2–4 were
flanked by loxP sites. (D–L) Upper two rows: In situ detection of Lhx5 mRNA
on sagittal sections of E12.5 embryo brains (genotypes as indicated). Scale
bar in (G), 500µm. Arrows show the localization of the MBO. (E,H,K)
High-magnification of the areas framed in (D,G,J). Lower row (F,I,L): Antibody
detection of LHX5 protein on parallel sections to those shown in (D,G,J).
Scale bar in (I), 100µm. Arrows show the localization of the MBO.
heterozygous Foxb1Cre−eGFP/+ mice, which show a normal
phenotype (Zhao et al., 2007, 2008), Foxb1Cre−eGFP/Cre−eGFP
homozygotes were not used in this study.
ROSA26R Reporter Mouse Line
Upon Cre-recombination, cells express ß-galactosidase (Soriano,
1999).
Tbx3 Mouse Mutant Line (Tbx3+/−)
Histological material from Tbx3−/− mouse mutants
(Hoogaars et al., 2007) was kindly provided by O. Trowe
and A. Kispert (University of Hannover, Germany) with
permission of V.M. Christoffels (University of Amsterdam, The
Netherlands).
Immunohistochemistry
Embryos or embryonic brains were dissected, fixed in 4%
paraformaldehyde, embedded in paraffin, and sectioned at
10µm. Immunofluorescent stainings were performed according
to standard protocols. For antigen retrieval the sections were
immersed in Tris-EDTA-Buffer pH 9 (10mM Tris, 1mM EDTA,
0,05% Tween-20) and treated in a Silit Sicomatic t-plus pressure
cooker (2 rings, 10min). The following primary antibodies were
used: mouse anti-neurofilament 2H3 (Developmental Studies
Hybridoma Bank, Iowa City, 1:100), chicken anti-GFP (Abcam
Ab13970, 1:100), mouse monoclonal antibody “4F2” anti-
LHX1 and LHX5 (Developmental Studies Hybridoma Bank,
Iowa City, 1:100), mouse Ki67 (Becton Dickinson 550609,
1:100), mouse anti-ßIII-tubulin (Sigma-Aldrich T8660, 1:100),
rat anti-BrdU (Abcam Ab6326, 1:100), mouse anti-BrdU/IddU
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(Becton-Dickinson 340649, 1:100), and rabbit anti-active Caspase
3 (Abcam Ab13847, 1:300). Secondary antibodies: anti-chicken
IgG Alexa Fluor 488 (Life Technologies, 1:300), anti-rabbit IgG
Alexa Fluor 488 (Life Technologies, 1:300), anti-mouse IgGAlexa
Fluor 488 (Life Technologie, 1:300), anti-rat IgG Alexa Fluor 568
(Life Technologies, 1:300), and anti-mouse IgG Alexa Fluor 594
(Life Technologies, 1:300). Cell nuclei were stained with DAPI
(Roth, 1:10000) or TO-PRO-3 (Life Technologies, 1:2000).
Measurements of MBO Size
For the measurements of MBO size (Figure 4I) we first visualized
the MBO on sections by labeling it with an anti-GFP antibody,
thenmeasured the labeled area (in pixels) with the public domain
software ImageJ. We did this for every section with MBO and
added up all theMBO-section areas measured in every individual
embryo. The result was the sum of the MBO section areas for
mutants and controls.
In Situ Hybridization
Templates were amplified by PCR from cDNA and probes were
synthesized using the Roche DIG RNA labeling Mix. In situ
hybridization was performed on paraffin sections according to
previously described protocols (Blaess et al., 2011). The sections
were counterstained with 0.1% Eosin.
Microarray
The mamillary neuroepithelium of E10.5 wild type and mutant
embryos was dissected and directly frozen at −80◦C. The RNA
was preserved with RNAlater ICE (Life Technologies) and sent to
MFT Services Tübingen, Germany, for microarray experiments
and basic bioinformatical analysis. These experiments were done
using the Affymetrix Gene ChipMouse Gene 1.1 ST Array Plates.
The “heat map” was generated by using the TM4 Software. All
Microarray samples are available on the GEO database.
Quantitative PCR
The quantitative PCR was performed according to MIQE
guidelines (Bustin et al., 2009). RNA was isolated using the
RNeasy Plus Micro Kit (Qiagen) and RNA integrity was checked
on an agarose gel. The RNA was reverse transcribed using the
M-MLV Reverse Transcriptase (Promega). Quantitative PCR
was performed using Power SYBR green PCR Master Mix
(Applied Biosystems) and a Step One Plus Real-Time PCR
System (Applied Biosystems). Quantificationwas performedwith
the delta-delta Ct method and Ef1 was used as endogenous
control (reference gene).
Cell Culture
To generate a stably transfected Lhx5-expressing Neuro2a cell
line, a construct was generated that added a FLAG-tag to the
C-terminus of LHX5 and that controls the expression of Lhx5
under the Ptight-promotor of the Tet-On Advanced Inducible
Gene Expression System (Clontech). The cells were cotransfected
with this construct and the pTet-ON-Advanced vector (3:1) by
using FUGENE HD Transfection Reagent (Promega). The cells
were selected in medium containing 1mg/ml G418 and clones
that showed a doxycycline-dependent, homogenous expression
of Lhx5 were frozen for further experiments.
ChIP-Seq
The ChIP-Seq experiments were performed according to
published protocols (Robertson et al., 2007; Schmidt et al., 2009).
We treated the cells of our Lhx5-expressing Neuro2a cells
(see above) with doxycycline for 24 h to induce Lhx5 expression,
fixed the cells for 10min in 1% formaldehyde and sonicated
to generate fragments of approximately 200 bp. We performed
chromatin immunoprecipitation overnight using an anti-FLAG
antibody (Sigma) at 4◦C, then removed protein and RNA by
enzymatic digestion and sent the purified DNA to the Deep
Sequencing Facility (Heidelberg University, Germany). High-
throughput sequencing was performed using the NEB ChIPseq
Master Mix Prep kit for Illumina and an Illumina HiSeq2000
instrument. All ChIP-Seq samples are available on the GEO
database. The data obtained were analyzed using the tools of
the Galaxy project (Giardine et al., 2005). Sequence reads were
mapped to the mm9 genome assembly with Bowtie (Trapnell and
Salzberg, 2009) and unmapped reads were removed. Peak calling
was performed with MACS using a M-FOLD value of 10 and a p-
value cutoff of 1e-05. The input sequences were used as a control.
The peaks were annotated with PeakAnalyzer 1.4 (Salmon-Divon
et al., 2010) using the “nearest downstream gene”method. For the
identification of enriched motifs we used DREME (Bailey, 2011).
As a control, we performed the same analysis with cells that only
expressed the FLAG-tag. In this control only 56 peaks were found
and no meaningful binding motif was identified in the DREME
analysis.
Luciferase Assay
Luciferase Assays were performed in the stably transfected
Neuro2a cell line using the Dual-Luciferase Reporter Assay
System (Promega). The identified LHX5 binding sites were
cloned into a luciferase reporter pGL4.26 (Promega) and
a Lmo1 expression vector (Origene MC203585) was used
for competition experiments. TurboFect Transfection Reagent
(Thermo Scientific) was used for the transfection of the Lhx5
expressing Neuro2a cell line. Transfected cells were treated
with doxycycline to induce Lhx5 expression. Two independent
experiments with triplicates were performed.
Cell Cycle Analysis
The cell cycle analysis was performed according to published
methods (Martynoga et al., 2005). In this protocol, timed-
pregnant mice were first injected intra-peritoneally with 0.05mg
iododeoxyuridine (IddU, Sigma) in 0.9% NaCl per gram of
body weight and then 1.5 h later with the same dose of
bromodeoxyuridine (BrdU) (Sigma). After an additional 30min,
the mice were sacrificed and the embryos collected. Paraffin
sections (8µm) were obtained and IddU and BrdU labeled
cells were detected using standard immunohistochemistry. IddU-
positive and IddU/BrdU-double positive cells were quantified
and the length of the S-phase and of the whole cell cycle were
calculated according to published formulas (Martynoga et al.,
2005).
ß-Galactosidase Activity Detection
ß-Galactosidase activity was detected as described (Koenen et al.,
1982). Embryos from timed pregnancies were collected and
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directly frozen in OCT at−80◦C. The embryos were cut (20µm)
and the sections were fixed for 5min in 1% paraformaldehyde,
0.2% glutaraldehyde and 0.2% NP-40 in PBS. The sections were
then rinsed and incubated in staining solution (1mg/ml X-gal,
5mM K3Fe(CN)6, 5mM K4FE(CN)6 and 2mM MgCl2 in PBS)
overnight in the dark at RT. The sections were counterstained
with Nuclear Fast Red.
Results
Lhx5 Expression in the Presumptive Mamillary
Region
In order to investigate how the formation of the MBO is
regulated we set out to analyze the function of the candidate
gene Lhx5. Lhx5 is expressed in the caudal hypothalamus of
the mouse as early as E9.5, approximately the time when
Shh is specifically downregulated in this area (Sheng et al.,
1997) The MBO is derived from the mamillary recess (Altman
and Bayer, 1986), present in the mouse from E11.5. We
detected Lhx5 transcripts by ISH at E11.5 in the presumptive
mamillary neuroepithelium (ventricular zone) (medial sections)
(Figure 1A) as well as in the earliest post-mitotic layer (mantle
layer) of the mamillary region (Figure 1B). Later, at E18.5, when
most nuclei and axonal tracts are already clearly recognizable,
Lhx5 expression persisted in the MBO labeling it in a specific
and strong way (Figures 1C,D). Detailed expression patterns
can be found in databases (Allen-Institute-for-Brain-Science,
2009).
The presence of Lhx5 expression from the stage when Shh
is downregulated in the ventricular zone until the MBO is fully
formed suggested a role spanning the entire specification and
differentiation of this nucleus and a possible link between the
specification of the mamillary region as a separate hypothalamic
field, and the specification of the MBO as a unique neuronal
aggregate inside this field.
Biallelic Disruption of Intronic Sequences of Lhx5
Causes LHX5 Protein Loss and Abnormal
Phenotype
In order to explore the role of Lhx5 in MBO development we
generated a novel conditional Lhx5 mouse line (Figures 2A–C).
The PGK-neo cassette was flanked by FRT sites and was
removed by crossing with the FLPeR deleter mouse (Farley
et al., 2000). Unexpectedly, we found high embryonic lethality
for the non-Cre-recombined conditional mouse line: out of
747 mice from this line surviving after weaning only three
(0.4%) were homozygous (Lhx5fl/fl). We hypothesized that the
loxP insertions in intronic regions could have disrupted a
hitherto unknown regulatory element necessary for appropriate
RNA processing, as has been reported in a number of
other mutants (see for instance, Meyers et al., 1998; Nagy
et al., 1998; Kist et al., 2005). This could result in a
reduced production of LHX5 protein in Lhx5fl/fl mice and
a hypomorph phenotype. To explore this possibility we first
detected Lhx5 mRNA on histological sections of Lhx5fl/fl
embryo brains plus two other related genotypes as controls
(Figure 2; Supplementary Figures 1, 2). As positive control we
FIGURE 3 | Lhx5 mRNA and LHX5 protein in Lhx5fl/fl mutants. (A,B)
Nissl staining of the hippocampus of Lhx5fl/+ (A) and Lhx5fl/fl mutant (B)
E18.5 embryos. Arrows indicate the dentate gyrus in (A) and its absence in
(B). (C,D) Immunohistochemistry against calretinin (red) on Lhx5fl/+ and
Lhx5fl/fl mutant E12.5 embryos, counterstaining with DAPI (blue). Arrows in
(C,D) show the presence of an ectopic Cajal-Retzius cell cluster in the mutant
telencephalon. Scale bars: (A,B): 500µm; (C,D): 100µm.
used Foxb1Cre−eGFP/+ mouse embryos, which show normal
phenotype (Zhao et al., 2007, 2008). Mouse embryos with the
Lhx5fl/fl genotype (i.e., non-Cre-recombined) showed apparent
decrease of mRNA expression as compared to Foxb1Cre−eGFP/+
embryos (compare Figure 2D to Figure 2G; Figure 2E to
Figure 2H). As negative controls we used mouse embryos with
Foxb1Cre−eGFP/+; Lhx5fl/fl genotypes (i.e., conditional mutants
for Lhx5); these showed as expected loss of Lhx5 expression
in the mamillary region, where Foxb1 and Lhx5 normally
coexpress (Figures 2J,K). Quantitation of mRNA by qPCR
in Lhx5fl/fl and Lhx5+/+ embryos showed a non-statistically
significant tendence to smaller values in the mutant (not
shown).
Then we used an antibody specific for both the LHX1 and
the LHX5 proteins on parallel sections (Figures 2F,I,L) to those
hybridized for mRNA. On the sections from Lhx5fl/fl embryos we
could not detect any LHX1/5; the Foxb1Cre−eGFP/+ embryos, on
the contrary, showed strong protein expression in the mamillary
body as expected (compare Figure 2F to Figure 2I). Finally,
the mamillary region of the Foxb1Cre−eGFP/+; Lhx5fl/fl embryos
did not show LHX1/5 protein either (compare Figure 2I to
Figure 2L).
Moreover, phenotypical analysis of Lhx5fl/fl embryos prior
to Cre-recombination revealed a mutant phenotype resembling
the published phenotypes of the Lhx5 full mutant— a defective
hippocampus (Figures 3A,B) (Zhao et al., 1999) and ectopic
Cajal Retzius cells forming a cluster in the caudal telencephalon
(Figures 3C,D) (Miquelajáuregui et al., 2010).
We concluded that Lhx5fl/fl embryos show a hypomorph
phenotype probably caused by inefficient protein synthesis after
insertion of a loxP site into an intron sequence with regulatory
functions.
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Lhx5 is Essential for the Development of the
Mamillary Region
To analyze the role of Lhx5 in the development of the MBO, we
crossed the Lhx5fl/fl conditional line with the Foxb1Cre−eGFP/+
line (Zhao et al., 2007). Since Foxb1 is a specific marker
of the developing MBO (Alvarez-Bolado et al., 2000b), this
crossing leads to a conditional inactivation of Lhx5 in the
MBO. In Nissl-stained sagittal sections at E18.5 the MBO
of Foxb1Cre−eGFP/+ mice was visible as a compact mass of
neurons giving rise to a characteristic axonal bundle (the
principal mamillary tract) (Figure 4A). These structures were
absent in Foxb1Cre−eGFP/+;Lhx5fl/fl brains (Figure 4B) as well
as in Lhx5fl/fl brains (Figure 4C). The absence of the MBO
was confirmed by loss of GFP antibody detection (enhanced
GFP reporter of the iCre-IRES-eGFP-cassette), confirming the
histological result (Figures 4D,E; the non-recombined Lhx5fl/fl
brains lack of course the eGFP reporter). Finally, antibody
detection of LHX5 protein (Figures 4F–H) showed that they
are indeed lost in the non-recombined Lhx5fl/fl brains as well
as in the ones from Foxb1-Cre-eGFP+/−;Lhx5fl/fl crosses. The
loss of the MBO in the non-recombined Lhx5fl/fl embryos was
indistinguishable from that in the Foxb1-Cre-eGFP+/−;Lhx5fl/fl
FIGURE 4 | The MBO in Lhx5fl/fl mutant embryos fails to increase in
size. (A–C) Nissl staining of sagittal sections of E18.5 brains, rostral to the
left, genotypes as indicated. (D,E) Immunohistochemistry against GFP
(green; from the reporter gene included in the Foxb1Cre−eGFP/+ line) and
neurofilaments (red), counterstained with DAPI (blue). (The Lhx5fl/fl mutant is
not crossed with Foxb1Cre−eGFP/+ and therefore has no eGFP reporter
gene to be detected). (F–H) Antibody detection of LHX5 protein (red),
counterstained with DAPI (blue). Arrows in (A,D) show the principal mamillary
tract. The asterisks show the place where the MBO would be expected.
Scale bar in (A): 100µm. MBO, mamillary body; P, Pons. (I) MBO size
quantitation during development; mean ±SD; n = 3 embryos per age and
genotype; n.s. not significant; *p < 0.05; **p < 0.01; ***p < 0.001.
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embryos. To quantify the loss of the MBO we labeled
sagittal sections of Foxb1-Cre-eGFP+/−;Lhx5fl/+and Foxb1-Cre-
eGFP+/−;Lhx5fl/fl with anti-GFP antibodies and measured the
MBO area (using ImageJ software) (Figure 4I), uncovering a
failure of the mutant MBO to grow to a normal size from E13.5
on.
Proliferation and Apoptosis are Not Altered in the
Lhx5fl/fl MBO
Next we asked if either a defect in proliferation or increased
apoptosis were responsible for the reduction in MBO size in
the Lhx5-deficient hypothalamus. An initial analysis of mitotic
and post-mitotic compartments in the early mamillary region
using antibodies against the proliferation marker Ki67 (Starborg
et al., 1996) and the neuronal marker beta-III-tubulin revealed
no difference between Lhx5fl/+ and Lhx5fl/fl (Figures 5A–D). We
then applied the IddU/BrdU method (Nowakowski et al., 1989;
Martynoga et al., 2005) to analyze cell cycle length in the Lhx5fl/+
and Lhx5fl/fl mamillary neuroepithelium of E10.5–E12.5 embryos
(Figures 5E,F). This method allows for calculation of the length
of the S-phase of the cell cycle. One proliferation marker,
IddU, is injected in pregnant mice at one time-point. After a
known interval (90min), a second proliferation marker, BrdU
(which can be independently detected with specific antibodies)
is injected. Both label the DNA synthesized during the S-phase.
After 30min, the embryonic brains are collected and the cells
labeled either only by IddU or by both IddU+ BrdU are counted.
From the ratio between both numbers of cells, and since we know
the interval during which cells can incorporate IddU but not
BrdU (90min.), the length of the S-phase can be easily calculated
(see Martynoga et al., 2005 for details).
The Lhx5fl/fl showed no change in S-phase duration
(Figure 5I) or in the duration of the cell cycle (Figure 5J),
indicating that Lhx5 is not essential for MBO proliferation. To
investigate a possible increase in apoptosis in the Lhx5-deficient
MBO, we labeled sections of Lhx5fl/fl and Lhx5fl/+ caudal
hypothalamus with an antibody against active Caspase3
(Figures 5G,H) and quantified the number of apoptotic cells
at different developmental stages. Our results showed that the
number of apoptotic cells was not increased in the Lhx5-deficient
hypothalamus between E11.5 and E14.5 (Figure 5K). Actually,
the number of apoptotic cells per section detected at E11.5 was,
although small in any case, higher in control animals than in
mutants (Figure 5K). Although it could be speculated about the
biological significance or lack thereof of this finding, it could
perhaps be a reflection of the altered properties of the mutant
MBO cells already at this age.
In any case, a decrease in proliferation or an increase in cell
death is unlikely causes for the reduction of the MBO in the
absence of Lhx5.
Lhx5 Controls MBO Expression of Lmo1 and of
the Cell Fate Determinants Tbx3, Olig2, and Otp
To understand the molecular basis of the MBO hypoplasia
observed in Lhx5fl/fl embryos we performed comparative
expression profiling using microarrays. We extracted total
RNA from the caudal hypothalamus of wild type and Lhx5fl/fl
FIGURE 5 | Normal proliferation and apoptosis in the Lhx5fl/fl mutant.
(A–D) Immunohistochemistry against Ki67 (red) and ßIII-Tubulin (green) in
sections through the ventricular zone of the mamillary region of E12.5 Lhx5fl/+
and Lhx5fl/fl mutant embryos, DAPI (blue) as counterstaining. As expected, in
the Lhx5fl/+ (A,B) cells in the ventricular zone were Ki67-positive (A) and
mantle cells (young post-mitotic neurons) were ß-III-Tubulin positive (B).
Similar results were found in Lhx5fl/fl mutant embryos (C,D). (E,F)
Immunohistochemistry to detect IddU (green) and BrdU/IddU (red) in sections
of E12.5 Lhx5fl/+ and mutant embryos, TO-PRO-III (blue) as counterstaining.
IddU and BrdU/IddU could be detected in cells of the Lhx5fl/+ as well as in
cells of the mutant neuroepithelium. The signal could be clearly differentiated
between Iddu positive (green) and IddU/BrdU double positive (yellow) cells
(E,F). (G, H) Immunohistochemistry for the detection of active Caspase 3
(green) in section of E12.5 Lhx5fl/+ and mutant embryos, DAPI (blue) as
counterstaining. (I,J) Neither the duration of the S-phase (I) nor that of the
whole cell cycle (J) in the mamillary ventricular zone showed differences
between Lhx5fl/+ and Lhx5fl/fl mutant E10.5 through E12.5 embryos. (K) The
number of apoptotic cells in the caudal hypothalamus was not increased in
Lhx5fl/fl mutant E11.5 through E14.5 embryos. Abbreviations: V: ventricle,
MBO: mamillary body; Arrows in (G,H) indicate active Caspase 3 positive cells;
Scale bars: 100µm; n.s. not significant, *p < 0.05; mean ± SEM, n = 3
embryos.
mouse brains. Since tissue loss in the mutant could bias the
results, we collected the tissue at E10.5, before any reduction in
MBO size is apparent in the mutant (Figure 4I). Unsupervised
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hierarchical clustering of genes that were at least 1.5-fold up- or
downregulated with P < 0.05 yielded a heat map (Figure 6A)
indicating that the global gene expression patterns in embryos
of the same genotype clustered together and that wild type
and mutant samples were clearly distinct. Likewise, principal
component analysis showed that mutant and wild type samples
separate well from each other (Figure 6B). In this way we
detected 56 downregulated and 41 upregulated named genes (as
opposed to not yet identified transcripts like RIKEN clones, etc.)
(Supplementary Table 1). After qRT-PCR validation we selected
15 candidates for further analysis (Figures 6C–E) including the
cell fate determinants Tbx3, Olig2, and Otp as well as Lmo1,
an interaction partner of LDB, the obligate cofactor of LHX
proteins (Bach, 2000). In order to visualize the changes in spatial
expression patterns, in situ hybridization analysis on tissue
sections of E12.5 Lhx5fl/+ and Lhx5fl/fl embryos was performed
(Supplementary Figure 3). All candidate genes downregulated
in the Lhx5fl/fl mutant (Figures 6C–E) were expressed in the
Lhx5fl/+ mamillary region (either in the neuroepithelium or in
the mantle layer) and appeared reduced or absent in the mutant
(Supplementary Figure 3). Some downregulated candidates
showed complete loss of expression: Foxb2 (Supplementary
Figures 3E,F), Ntm (Supplementary Figures 3Q,R), Lypd1
(Supplementary Figures 3S,T) and Cx36 (Supplementary
Figures 3U,V). Others showed a strong reduction in labeling:
Otp (Supplementary Figures 3G,H), Barhl1 (Supplementary
Figures 3K,L), Nkx2.4 (Supplementary Figures 3C,D), Olig2
(Supplementary Figures 3I,J). Finally, other downregulated
candidates showed pattern changes, like Tbx3 (Supplementary
Figures 3A,B). As for the upregulated, Wnt5a (Supplementary
Figures 3C′,D′) and Lrtm1 (Supplementary Figures 3W,X)
showed clear ectopic expression in the mutant MBO, while Gal
(Supplementary Figures 3A′,B′) showed increase in intensity.
The microarray data have been deposited in NCBI’s Gene
Expression Omnibus (Edgar et al., 2002) and are accessible
through the GEO Series accession number GSE61614 and
the link http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=
yxgbokgqrvkdjif&acc=GSE61614.
LMO1 is a Possible Functional Antagonist of
LHX5
In order to elucidate whether the regulatory interactions
observed above are direct we used chromatin
immunoprecipitation followed by massively parallel sequencing
(ChIP-Seq) (Robertson et al., 2007). Performing this analysis
on primary tissue would have been the best choice. This was
however not possible since there is no ChIP-grade available
antibody against LHX5 (and the only antibody against LHX5
known to us identifies also LHX1). For this reason we chose to
transfect a construct expressing a fusion protein of Lhx5 plus
FLAG tag (which can be reliably identified with antibodies)
into a stable cell line known to express Lhx5. Then we used
the Tet-On Advanced Inducible Gene Expression System to
regulate the Lhx5 expression level so that it mimics the natural
expression level (see Materials and Methods for details). We
identified 546 possible LHX5 binding sites, which we assigned
to corresponding genes using the nearest downstream method
FIGURE 6 | Identification of genes that are downstream Lhx5.
Microarray analysis of wild type and Lhx5fl/fl mutant E10.5 mamillary
neuroepithelium and qRT-PCR validation of the identified candidates; (A) “Heat
map” showing the expression of the identified candidates in all samples. (B)
Principal component analysis of the microarray samples. (C) “Heat map”
showing the expression of the candidates for qPCR analysis in all samples.
(D,E) The qPCR validation identified 12 candidates downregulated (p < 0.05)
(D) and 3 candidates upregulated in the Lhx5fl/fl mutant (p < 0.05) (E).
Mean ± SD; n = 3 biological replicates.
(Peak Annotation with Peak Analyzer). We then analyzed these
binding sites for enriched motifs using the DREME software
(Bailey, 2011) and found a motif (Figure 7A) that is enriched in
32.18% of the binding sites and corresponds to a predicted LHX5
binding motif (Berger et al., 2008). Of the loci corresponding
to qPCR-validated microarray candidates, three showed this
motif— Lmo1, Tbx3, and Foxb2. We then performed luciferase
assays to test whether these binding sites can regulate expression
of their downstream genes; the results indicated (Figure 7B)
that Lmo1, Foxb2, and Tbx3 are possible direct targets of LHX5
(Figure 7B). LIM-domain-only (LMO) proteins (like LMO1)
can negatively regulate the function of LIM-HD transcription
factors by competing with them for binding to the dimer of their
obligate co-factor LIM domain-binding protein (LDB) (Bach,
2000; Chen et al., 2010). When the two binding domains of the
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FIGURE 7 | Identification of direct LHX5 targets and negative
regulation of the LHX5 function by LMO1. (A) Position weight matrix of the
binding motif enriched in the identified LHX5 binding sequences. (B)
Luciferase assay validation of the identified LHX5 binding sites for Lmo1,
Foxb2, and Tbx3 in the doxycyclin-dependent Lhx5-expressing Neuro2a cell
line. Mean ± SD, p < 0.001. (C) Model of the regulatory function of LMO1 on
LHX5 that we propose (see the Results Section for details). (D) Luciferase
assay in the doxycyclin-dependent Lhx5-expressing Neuro2a cell line stably
transfected with a vector expressing luciferase under the control of the LHX5
binding site found in Lmo1. Increasing amounts of an Lmo1 expression vector
were cotransfected. Mean ± SD.
LDB dimer are occupied by two copies of a LIM-homeodomain
protein (like LHX5), this protein is active as a transcriptional
regulator. On the contrary, if one of the LIM copies is substituted
by an LMO protein, the LIM-homeodomain transcription factor
is not active anymore. The downregulation of Lmo1 that we
observed in the Lhx5 mutant suggests that transcription of this
negative LHX regulator, in turn, is activated by LHX5, thereby
providing a negative feedback loop for Lhx5 (Figure 7C). We
used luciferase assays to test this hypothesis and found that
LMO1 exerts dose-dependent inhibition of transcriptional
activation from the LHX5 binding site (Figure 7D). In summary,
we showed that Tbx3, Foxb2, and Lmo1 are possible direct targets
of LHX5 and, additionally, that LMO1 negatively regulates LHX5
via a negative feedback loop.
Tbx3 has a Role in MBO Development
One of these genes, Tbx3, has an important role in the
development of the hypothalamus (Manning et al., 2006;
Trowe et al., 2013). We examined the expression of Tbx3 at
three different medio-lateral levels in our mutants at E12.5
(Figures 8A–F) and found a strong reduction in the expression
domain in the mutant. This reduction affected not only
the rostro-caudal extension of the midline (Figures 8A,C vs.
Figures 8B,D) but was also evident at more lateral levels
(Figures 8E,F). We then hypothesized that Tbx3 is involved in
MBO development, and on this basis predicted MBO defects in
FIGURE 8 | Tbx3 expression is reduced in the Lhx5fl/fl mutant. (A–F) in
situ detection of Tbx3 expression in Lhx5fl/+ and Lhx5fl/fl mutant E12.5
embryos. Three different medio-lateral levels are shown (from top to bottom).
Arrows indicate the boundaries of Tbx3 expression in (A–D) and the lateral
extension of the Tbx3 expression domain in (E,F). (G–N)
Immunohistochemistry against LHX1/5 (red) and neurofilaments (green) in
Tbx3 −/− and control E14.5 embryos, counterstaining with DAPI. (G,J) show
detection of LHX1/5 in the MBO of control (G) and Tbx3−/− mutant (J). (H,K)
show LHX1/5 plus neurofilaments in the MBO of control (H) and Tbx3−/−
mutant (K). (I,L) show the same panels as in (H,K) with thick lines indicating
the MBO profile and thin lines indicating the principal mamillary tract axons.
(M,N) show a higher magnification view of the axons of the principal mamillary
tract in controls and mutants. Arrowheads indicate the axons of the principal
mamillary tract. Asterisks indicate the position of the MBO. Scale bars: (A–F),
500µm; (E–N), 100µm.
Tbx3-deficient brains. Examination of the hypothalamus of Tbx3
mutant mice (Hoogaars et al., 2007) at E14.5 showed a reduced
MBO with abnormal morphology (Figures 8G–L) as well as a
Frontiers in Neuroanatomy | www.frontiersin.org 9 August 2015 | Volume 9 | Article 113
Heide et al. Lhx5 in the developing hypothalamus
FIGURE 9 | Shh domain expanded in the Lhx5fl/fl mutant. In situ
detection of Shh expression in Lhx5fl/+ and Lhx5fl/fl mutant E11.5 (A,B) and
E12.5 (C,D) embryos. Lines with arrowed ends indicate the size of the
Shh-free region in the midline. Scale bars: 500µm.
strong reduction in axonal projections (Figures 8M,N). Since the
Tbx3mutant embryos die before birth, usually around E14.5, we
could not ascertain the possible total loss of the MBO at later
stages.
The Shh Domain is Enlarged in Lhx5 Mutant
Hypothalamic Midline
The reduction in Tbx3 is very intriguing, since this gene (Tbx2
in chicken) is needed to inhibit Shh expression in the tubero-
mamillary region (Manning et al., 2006; Trowe et al., 2013),
an event indispensable for this region to differentiate (Manning
et al., 2006). We hypothesized that the downregulation of Tbx3
in Lhx5 mutants would result in an abnormal expansion of the
territory of Shh in the caudal hypothalamus. In situ detection
of Shh expression confirmed that, in the Lhx5 mutants, the
domain where Shh is normally downregulated becomes very
small (Figures 9A,B). We obtained similar results at E12.5, when
Shh expression is at its peak in this region, after which it
starts to disappear (Figures 9C,D). We concluded that failure to
completely inhibit Shh expression in the tubero-mamillary region
is a possible mechanism explaining the MBO phenotype that we
observe in the Lhx5mutants.
The Foxb1 Lineage is Deficiently Specified in the
Lhx5-deficient Caudal Hypothalamus
Other transcription factor genes downregulated in our Lhx5
mutant are Olig2 and Otp, known to be involved in MBO
development (see Discussion), as well as Foxb2, Barhl1, Nkx2-
4, and Arx. Since we did not detect changes in apoptosis or
proliferation defects, it seems likely that the cells constituting
the MBO primordium are present in the mutants but that they
have lost their specific MBO identity. The subsequent loss of cell
adhesion protein expression (Cx36-Gdj and Ntm) could underlie
the loss of morphological appearance of the MBO and make it
FIGURE 10 | The Foxb1 lineage of the MBO is present in the Lhx5fl/fl
mutant. (A,B) ß-galactosidase activity (blue) reveals the Foxb1 lineage in
sagittal sections of E13.5 embryos of Foxb1Cre−eGFP/+;ROSA26R;Lhx5fl/+
(A) and Foxb1Cre−eGFP/+;ROSA26R;Lhx5fl/fl (B). Arrows show the extension
of the Foxb1 lineage in the caudal hypothalamus. (C–J) In situ hybridization
detection of marker gene expression (as indicated) on sagittal sections of
E12.5 Lhx5fl/+ and Lhx5fl/fl mutant embryos. Arrowheads mark the position
of the MBO. Scale bars: 500µm.
undetectable. Since Foxb1 is an early marker of the mamillary
neuroepithelium and the developing MBO (Kaestner et al., 1996;
Alvarez-Bolado et al., 2000b), we used β-galactosidase detection
in Foxb1-Cre;ROSA26R mice to reveal the MBO lineage. In
Foxb1-Cre+/−;Lhx5fl/+;Rosa26R+ a large caudal hypothalamic
domain including the mamillary area was labeled in E13.5
embryos (Figure 10A). In Foxb1-Cre+/−;Lhx5fl/fl;Rosa26R+,
however, there is only a restricted, round domain formed by
cells of the Foxb1 lineage at E13.5 (Figure 10B), corresponding
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FIGURE 11 | The tuberal and prethalamic regions seem unaffected in
the Lhx5fl/fl mutant. In situ hybridization detection of marker gene
expression (as indicated) on sections of E12.5 embryos of in Lhx5fl/+ and
Lhx5fl/fl mice (as indicated). Arrows indicate comparable points in the
expression domains of controls and mutants. (A–F) Pitx2, Th, and Pitx3 are
midbrain markers. (G–J) Arx and Olig2 are prethalamus markers. (K,L) Tbr1 is
a marker of the thalamic eminence. (M–R) SF-1, Lef1 and Pomc are tuberal
markers. See Results Section for details. Scale bars: 500µm (in A, for
sagittals; in G, for transverse sections).
in appearance and position to the MBO. We assume that
these are abnormally undifferentiated cells originally fated
for the MBO. Expression analysis of specific MBO markers
Foxb1, Lhx1, Sim1 and Sim2 (Figures 10C,E,G,I) showed strong
downregulation in themutant (Figures 10D,F,H,J). Additionally,
the preserved expression of Lhx1 in regions other than the
mamillary (Figures 10I,J) indicates that the result is specific. This
result confirmed the presence of MBO cells with abnormal loss of
identity in our mutant.
Overall Hypothalamic Regional Specification
Appears Correct in the Lhx5 Mutant
To learn more about the extension of the changes observed
in the Lhx5 mutant, we performed a general analysis with
markers for adjacent regions as well as markers of the
tuberal region. Hypothetically, Lhx5 might act in posterior
hypothalamic progenitors to repress midbrain identity and
at the same time promoting expression of MBO markers.
Therefore, in the mutants, the rostral end of the ventral
midbrain would abnormally extend into the mamillary
region of the hypothalamus. We tested this hypothesis by
detecting three genetic markers of the ventral midbrain whose
expression patterns inform about the rostral extension of
the ventral midbrain: Pitx2, tyrosine hydroxylase (Th), and
Pitx3 (Figures 11A–F). The domains of these three markers
were essentially unaltered in the mutants (see arrows in
Figures 11A–F), which belied any expansion of the midbrain
domain into the Lhx5-deficient hypothalamus. Arx and Olig2 are
markers of the prethalamus, an Lhx5-expressing region adjacent
to the hypothalamus. Expression of both genes wasmaintained in
the mutants (Figures 11G–J). The expression of Tbr1, a marker
of the thalamic eminence, was not affected in the mutants either
(Figures 11K,L). Finally, we explored the expression of several
markers of the tuberal region. The expression of genes specific
for some important hypothalamic nuclei, like SF-1 (Nr5a1)
(marker of the ventromedial nucleus of the hypothalamus) and
Pomc (marker of the arcuate nucleus) was not changed in the
Lhx5 mutants (Figures 11M–P). Lef1, a marker of the boundary
between the mammillary and tuberal regions, was also essentially
unchanged in the mutants (Figures 11Q,R). Additionally,
we performed apoptosis (caspase 3) and proliferation (Ki67)
analyses on the hypothalamic tuberal region as well as the
prethalamus, which showed no change in the mutant (not
shown).
We concluded that the hypomorph allele of Lhx5 that we
have generated does not cause a general defect in hypothalamus
development, but its effects are mostly felt on theMBO. This said,
we have also observed gross alteration of pituitary development
in our mutants (not shown), due probably to the reduction in
Tbx3 expression (Tbx3 is essential for pituitary development,
Trowe et al., 2013).
Discussion
We attempted to elucidate the mechanisms downstream Shh
signaling by which the regions of the caudal hypothalamus
acquire their identity. The expression domain of Lhx5 is
appropriate for this gene to play a role in determining important
properties of the caudal hypothalamus. Therefore, we generated
a novel mutant allele giving rise to a hypomorph. Subsequent
expression analysis with microarrays and other experiments
have provided us with a series of candidate genes involved in
appropriate differentiation of the MBO. LHX5 regulates directly
or indirectly the onset or the maintenance of expression of these
genes and is therefore key to MBO development (Figure 12).
Two major pathways known to be involved in the development
of the tubero-mamillary region could be affected in the Lhx5
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FIGURE 12 | A possible network of Lhx5-regulated genes and
interactions related to MBO development and differentiation. Genes
downregulated (red arrows) or upregulated (blue arrows) according to
microarray data validated by qPCR have been placed into 5 “bins”. Bins 1–3
contain genes and interactions known to be essential for MBO development
(bin 1) or for the development of the hypothalamus (bins 2 and 3). Bin 4 shows
transcription factors specifically expressed in the MBO which have not been
proven essential for its development. Bin 5 contains effector genes (adhesion,
axonal guidance) expressed in the MBO and presumably involved in its
differentiation. Lmo1 has a reciprocal regulatory relation with Lhx5 not shared
with any of the other candidates. In gray, data from the literature.
mutant. One of them includes transcription factors Olig2 and
Otp acting upstream of Sim1 and 2 and finally Foxb1 for
differentiation and survival of the MBO. The second involves the
restricted inhibition of Shh byTbx3 to allow for tubero-mamillary
differentiation.
Olig2 and Otp Act Upstream of Sim1 and Sim2 in
MBO Development
Of the genes found in our expression analysis, some can be
readily related to the MBO phenotype. We have divided them
into five categories (Figure 12, bins 1–5). The first one contains
the transcription factors Olig2 and Otp. Olig2 activates Sim1 in
the developing zebrafish diencephalon (Borodovsky et al., 2009),
and the expression domain of Sim1 was strongly reduced in
our mutant (Figures 10E,F). Otp is required for Sim2 expression
in the mouse hypothalamus (Wang and Lufkin, 2000). Both
Sim1 and Sim2 are essential for MBO development (Marion
et al., 2005) and additionally they are required to maintain
MBO expression of the transcription factor Foxb1, which is itself
required for MBO development and survival (Alvarez-Bolado
et al., 2000a). This suggests that Lhx5 contributes to initiate
or maintain a transcriptional network that is required for the
specification of the MBO.
Tbx3 is Required for MBO Development
Downstream of Lhx5
In the chicken hypothalamus, Tbx2 is required to antagonize Shh
in the tubero-mamillary region in this way allowing it to acquire
hypothalamic fate (Manning et al., 2006). The same function is
performed by Tbx3 in the mouse (Trowe et al., 2013). We show
here that Tbx3 is a possible direct target of Lhx5 (Figure 6B),
that the Shh expression domain is inappropriately large in our
mutant (Figures 9C,D), and that the Tbx3-deficient brain has
an abnormal MBO (Figures 8G–L). Thus, Lhx5 is upstream of
three pathways all of which can independently cause the MBO
defects observed in our mutants (summarized in Figure 12,
bins 1–3).
IsWnt Inhibition through Lhx5 Required for MBO
Development?
In zebrafish (Kapsimali et al., 2004) and chicken (Manning
et al., 2006) hypothalamic fate acquisition requires Wnt pathway
inhibition. Lhx5 inhibits Wnt by acting upstream of the Wnt
antagonists Sfrp1a and Sfrp5 in zebrafish (Peng and Westerfield,
2006). Although to the best of our knowledge these interactions
have not yet been confirmed in the mouse, our observation that
Wnt5a (Figure 12, bin 2) is ectopically expressed in the MBO
(Supplementary Figures 3C′,D′) seems to agree with them. This
would suggest that a lack of antagonism of Wnt signaling in
this region may lead to a failure to acquire appropriate fate. On
the other hand, the increase in Wnt5a that we observe is very
small, and there are no signs of other genes of the Wnt pathway
altered in our mutant. For this reason we consider that this result
suggests someWnt involvement inMBOdevelopment, in general
agreement with published data on other models. But this line of
inquiry would need to be confirmed by further experiments in
the mouse.
Deficient MBO Specification in the Lhx5 Mutants
The final result of these alterations could be a reduction in the
region specified to produce MBO neurons as well as an imperfect
differentiation of the MBO-fated neurons that could still be
generated. Lhx5 mutants would have fewer MBO neurons and
they would be incorrectly specified. This deficient specification
would in turn cause loss of expression of specific markers
(Figure 12, bins 4, 5). Furthermore, the genes in the fifth bin
are involved in adhesion (Ntm, Cx36-Gdj) and axonal outgrowth
(Shootin1), which suggests that the loss of MBO identity may
additionally translate into a loss of specific aggregation of MBO
neurons and loss of the characteristic mamillary axonal tree. The
lack of changes in proliferation or apoptosis (Figure 5) together
with the persistence of a restricted group of Foxb1-lineage cells
in the mamillary region (Figures 10A,B) are consistent with this
hypothesis.
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LMO1 is a Possible Direct Target and Antagonist
of Lhx5
LMO proteins antagonize the function of LHX transcription
factors by competing with them for binding to the LHX obligate
partner LDB (Bach, 2000). Since we show that Lmo1 is a possible
direct target of LHX5, we predict that Lmo1 and Lhx5 are
arranged in a negative feedback loop and our luciferase assays
confirm this prediction (Figure 7D). A similar mechanism is in
operation in the developing thalamus between Lhx2 and Lmo3
(Chatterjee et al., 2012).
Zebrafish Vs. Mouse
The function of hypothalamic regulators seems to have been
highly conserved during evolution and zebrafish orthologs have
similar roles to their mouse counterparts (Machluf et al., 2011).
Therefore, it would be interesting to know if the proposed
gene regulatory network is evolutionary conserved and valid in
other organisms. In zebrafish, the mamillary region is specified
by the combined activity of transcription factors Fezf2, Otp,
Sim1a, and Foxb1.2 (Wolf and Ryu, 2013). At a stage when
neuronal specification takes place, the expression domains of
Fezf2, Otp, Foxb1.2, and Sim1a form distinct subdomains within
the zebrafish mamillary region giving rise to distinct mamillary
neuronal subpopulations (Wolf and Ryu, 2013). Here we show
that in the mouse Otp, Sim1, and Foxb1 are direct or indirect
targets of LHX5, which is essential for MBO development. Fezf2
is expressed early in the developing forebrain and controls
regionalization of the diencephalon in both zebrafish and mouse
(Hirata et al., 2006; Jeong et al., 2007; Shimizu and Hibi, 2009;
Scholpp and Lumsden, 2010). Furthermore, it is expressed in the
mousemamillary neuroepithelium, but not throughout the entire
MBO (Allen-Institute-for-Brain-Science, 2009). Fezf1- and Fezf2-
are responsible for the expression of Lhx5 in the subthalamus,
and the double mutant mouse exhibits a hippocampal phenotype
very similar to that of the Lhx5 mutant (Zhao et al., 1999; Hirata
et al., 2006). However, the MBO was intact in this double mutant
(Hirata et al., 2006). These results suggest that the pathways
underlying hypothalamic regional development are conserved to
a high degree.
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Supplementary Table1 | List of results of microarray expression profiling.
Supplementary Figure 1 | Medio-lateral series of sagittal sections
through the brain of mouse embryos (E12.5), genotypes as indicated
at the top. For each genotype, the left column shows in situ hybridization
for Lhx5 and the right column shows labeling of an adjacent section with
anti-LHX1/5 antibody (at higher magnification). The arrows indicate the
mamillary body primordium. Scale bars left column (ISH), 500 ìm; right
column (antibodies), 100 µm.
Supplementary Figure 2 | Same as Supplementary Figure 1, for the
Foxb1-Cre-eGFP+/− x Lhx5fl/fl genotype.
Supplementary Figure 3 | Expression pattern of qPCR-validated
candidates on Lhx5fl/+ and Lhx5fl/fl mutant embryos In situ
hybridization of qPCR-validated microarray candidates (as indicated)
on sagittal sections of E12.5 Lhx5fl/+ and Lhx5fl/fl mutant embryos.
Insets show MBO under higher magnification. Black arrows indicate the
position of the MBO; arrows after the gene name indicate downregulation
(red arrow) or upregulation (blue arrow) in microarrays and qPCR. Scale bar
(in A): 500 µm.
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